Search

Your search keyword '"Huber, Andreas"' showing total 596 results
Start Over Author "Huber, Andreas" Language english
596 results on '"Huber, Andreas"'

2. Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae

Author

Rass, Verena, Tymoszuk, Piotr, Sahanic, Sabina, Heim, Beatrice, Ausserhofer, Dietmar, Lindner, Anna, Kofler, Mario, Mahlknecht, Philipp, Boehm, Anna, Hüfner, Katharina, Pizzini, Alex, Sonnweber, Thomas, Kurz, Katharina, Pfeifer, Bernhard, Kiechl, Stefan, Peball, Marina, Kindl, Philipp, Putnina, Lauma, Fava, Elena, Djamshidian, Atbin, Huber, Andreas, Wiedermann, Christian J., Sperner-Unterweger, Barbara, Wöll, Ewald, Beer, Ronny, Schiefecker, Alois Josef, Bellmann-Weiler, Rosa, Bachler, Herbert, Tancevski, Ivan, Pfausler, Bettina, Piccoliori, Giuliano, Seppi, Klaus, Weiss, Günter, Löffler-Ragg, Judith, and Helbok, Raimund

Published
2023
Full Text
View/download PDF

4. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

Author

Abe, Wakana, Adan De Varona, Tania, Adiatullina, Daria, Aguilar Zapata, Daniel, Ahlers, Kevin, Aimo, Carolina, Akere, Ayoade, Akimova, Elena, Alatorre Alexander, Jorge, Aldrich, Logan, Ali Garcia, Ismael, Ali García, Karim, Allison, Lee, Alonso Zuñiga, Rosa, Aloysius, Ivan, Altclas, Javier, Alvarisqueta, Andres, Antila, Martti, Anton, Camila, Árboix Alamo, Elisabet, Arora, Samir, Avilés Felix, Ramón Alejandro, Bakhtina, Natalya, Barbero-Becerra, Varenka, Barragan-Reyes, Armando, Barreira, Alejandro, Barrett, Mitchell, Beran, Jiri, Berki, Nikolett, Berki, Viktoria, Betten, Richard, Binelli, Claudia, Brunzová, Lenka, Bussolari, Cecilia, Byargeon, Karianna, Bytnar, Justyna, Camberos, Carlos, Campos Corzo, Pedro, Cannon, Grazia, Canovi, Valentina, Carla da Rosa, Simone, Moser, Ana Caroline, Carrera Rivas, Luis, Casas, Marcelo Martin, Castañeda-Méndez, Paulo, Cavalcante, Ana, Cherepova, Eugenia, Chermenskii, Alexei, Clark, Lauren, Codeluppi, Mauro, Coelho, Flavia, Contreras, Belinda, Cran, Alex, Dao, Taylor, Dharma, Chrisette, Di Castri, Cosimo, Diaz Balocchi, Victoria, Durán, Omar, Earl, Kara, Ellery, Adam, Endo, Tomoko, Everding, Andrea, Fischer, Rainald, Fonseca, Benedito, Franklin, Chelsea C., Franz, Susan-Beatrice, Fumagalli, Anna, Galindo-Amaya, Mauricio, Galli, Mariagiulia, Gerna, Laura, Gil Ureña, Karolly, Gomes Antila, Henrikki, Gomes Maricato, Laura Ines, Goncalvez, Gabriela, Gonzalez, Martin, González-Lama, Jesús, Granier, Stephen, Granier, Jacob, Grunwald, Stephan, Guardeño-Ropero, David, Guberti, Monica, Guduri, Sridhar, Guerrero García, Carolina, Haggiagi, Jehad, Hale, Kacie, Hayashi, Toshimasa, Hermes, Maiara, Hernandez Colin, Dante, Hirai, Yuji, Hojo, Masayuki, Homma, Tetsuya, Hour, Billy, Huber, Andreas, Iacovelli, Diego, Ishibashi, Noriomi, Iwabe, Yutaro, Izumi, Shinyu, Jessen, Arne, Jessen, Heiko, Jeudy, Wilner, Jiménez Marcos, Marta, Johnson, Rebecca, Juárez-Hernández, Eva, Kabasawa, Kiyomi, Kamińska, Katarzyna, Kawabe, Megumi, Kemp, Angela, Khmelnitskiy, Oleg, Klassen, Carina, Kobrynska, Olena, Koleckar, Pavel, Korn, Stephanie, Kornmann, Marc, Kostenko, Viktor, Kovalchuk, Evgenii, Kovalchuk, Yana, Kümmerle, Tim, Lachmund, Ulrike, Lammersmann, Kerstin, Lastebasse, Flávio, Lattuada, Ivana, Lauer, Felicitas, Lebed, Kyrylo, Lebed, Olga, Lecona-Garcia, Diego, Leoni, Maria Christina, Lima, Marina, Little, Raymond, Little, Holly, Lizardi-Díaz, Andrea, Lobo-Becker, Michele, Luppi, Francesco, Macias, Veronica, Maesaki, Shigefumi, Magnaghi, Cristiano, Mancini, Annalisa, Mazur, Stanisław, Melnikova, Tatiana, Menchaca, Sergio, Menendez-Perez, Ibrahim, Międlar, Ewa, Mizunuma, Shuuichi, Mochalova, Anastasiya, Mohamed, Mihad, Moll, Theresa, Montalvo, Camila, Mottola, Amber, Mück, Birgit, Mussi Brugnolli, Rebeca, Nanda, Akanksha, Neuner, Dörthe, Ngwueke, Agatha, Noe, Sebastian, Novacek, Martin, Nuzzolo-Shihadeh, Laura, Obiekwe, Emeka, Ocampo Gaytán, Isaias G., Ohmagari, Norio, Ohta, Shin, Onyewuchi, Ptuonye, Pankov, Iurii, Pedrosa, Maurício, Peré, Yael, Pereyra, Alejandro, Perez, Eliana, Perez-Alba, Eduardo, Perpiña Lozano, Paloma, Perrei, Tanya, Peterson, Dena, Pierroti, Ligia, Pineda-Cárdenas, Felipe, Plascencia Sanchez, Teresa, Poletti, Camila, Pomaranzi, Chiara, Portes, Lisette, Postel, Nils, Ramirez, Monica, Ramírez, Isabel, Ramirez-Baena, Miguel, Ramjee, Mahadev, Ratti, Giovanna, Reeve, Jackie, Reichert, Petr, Reichertová, Petra, Reyes Garcia, Edgar Alejandro, Ricardo, Celso, Rodríguez Rodríguez, Nicomedes, Roldán Sánchez, Jaun, Romero-Lopez, Matilde, Rosales, Tyrone, Rosales, Harvey, Roshan, Mohamed, Roshan, Simran, Rovere Querini, Patrizia, Rutter, Heather, Sachwani, Sadaf, Sagara, Hironori, Sakai, Jun, Samson, Nina, Sánchez Mijangos, José Héctor, Sánchez, Liliana, Sánchez-González, Ana, Sandford, Micko, Santana, Laura, Santos de Carvalho, Felipe, Sasao, Reiko, Sato, Lubna, Scheuermann, Elizabeth, Schmidt, Olaf, Seki, Masafumi, Shaikh, Safia, Shimada, Daishi, Shinkai, Masaharu, Shinoda, Masahiro, Smith, Jackie, Solorzano, Fernando, Soncini, Silvia, Soregine, Katalin, Sosa, Erica, Sowade, Olalekan, Špinková, Veronika, Staniford, Ruth, Steigemann, Iska, Steiner, Vivien, Strelkov, Vladimir, Suárez Pineda, Cintya R., Suenaga, Hiroki, Suzaki, Shintaro, Swayze, Hannah, Tada, Yuji, Takeshita, Yuichiro, Takiguchi, Yasuo, Tanaka, Akihiko, Tarumoto, Norihito, Tatarintseva, Albina, Taubert, Michelle, Terenya, Elizaveta, Tinoco, César, Tomiyasu, Tomohiro, Torres-Vidal, Gladys, Trejo-Aguiar, Gabriela, Tsushima, Kenji, Tunstall, Emma, Turrà, Caterina, Valdes, Yoandy, Valencia Castro, Nelly, Visconti, Guilherme, Vitali, Giordano, Vutikullird, Apinya, Watti, Jezdancher, Werth, Doreen, Wilson, Cheyanne, Wilson, Philippe, Workman, Amy, Wörle, Pamela, Wyen, Christoph, Yamaguchi, Yoshiko, Yamamoto, Kei, Montgomery, Hugh, Hobbs, F D Richard, Padilla, Francisco, Arbetter, Douglas, Templeton, Alison, Seegobin, Seth, Kim, Kenneth, Campos, Jesus Abraham Simón, Arends, Rosalinda H, Brodek, Bryan H, Brooks, Dennis, Garbes, Pedro, Jimenez, Julieta, Koh, Gavin C K W, Padilla, Kelly W, Streicher, Katie, Viani, Rolando M, Alagappan, Vijay, Pangalos, Menelas N, and Esser, Mark T

Published
2022
Full Text
View/download PDF

7. Anti‐Spike IgG antibodies as correlates of protection against SARS‐CoV‐2 infection in the pre‐Omicron and Omicron era.

Author

Seekircher, Lisa, Astl, Manfred, Tschiderer, Lena, Wachter, Gregor A., Penz, Julia, Pfeifer, Bernhard, Huber, Andreas, Afonso, Pedro M., Gaber, Manfred, Schennach, Harald, Siller, Anita, and Willeit, Peter

Subjects
SARS-CoV-2 Omicron variant, ANTIBODY titer, IMMUNOGLOBULIN G, SEROCONVERSION, IMMUNOASSAY
Abstract

Anti‐Spike IgG antibodies against SARS‐CoV‐2, which are elicited by vaccination and infection, are correlates of protection against infection with pre‐Omicron variants. Whether this association can be generalized to infections with Omicron variants is unclear. We conducted a retrospective cohort study with 8457 blood donors in Tyrol, Austria, analyzing 15,340 anti‐Spike IgG antibody measurements from March 2021 to December 2022 assessed by Abbott SARS‐CoV‐2 IgG II chemiluminescent microparticle immunoassay. Using a Bayesian joint model, we estimated antibody trajectories and adjusted hazard ratios for incident SARS‐CoV‐2 infection ascertained by self‐report or seroconversion of anti‐Nucleocapsid antibodies. At the time of their earliest available anti‐Spike IgG antibody measurement (median November 23, 2021), participants had a median age of 46.0 years (IQR 32.8–55.2), with 45.3% being female, 41.3% having a prior SARS‐CoV‐2 infection, and 75.5% having received at least one dose of a COVID‐19 vaccine. Among 6159 participants with endpoint data, 3700 incident SARS‐CoV‐2 infections with predominantly Omicron sublineages were recorded over a median of 8.8 months (IQR 5.7–12.4). The age‐ and sex‐adjusted hazard ratio for SARS‐CoV‐2 associated with having twice the anti‐Spike IgG antibody titer was 0.875 (95% credible interval 0.868–0.881) overall, 0.842 (0.827–0.856) during 2021, and 0.884 (0.877–0.891) during 2022 (all p < 0.001). The associations were similar in females and males (Pinteraction = 0.673) and across age (Pinteraction = 0.590). Higher anti‐Spike IgG antibody titers were associated with reduced risk of incident SARS‐CoV‐2 infection across the entire observation period. While the magnitude of association was slightly weakened in the Omicron era, anti‐Spike IgG antibody continues to be a suitable correlate of protection against newer SARS‐CoV‐2 variants. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. Increased erythroferrone levels in malarial anaemia.

Author

Neyer, Peter J., Kaboré, Bérenger, Nakas, Christos T., Diallo, Salou, Tinto, Halidou, Post, Annelies, van der Ven, Andre J., Huber, Andreas R., Largiadèr, Carlo R., and Hammerer‐Lercher, Angelika

Subjects
IRON deficiency anemia, IRON in the body, ANEMIA, LABORATORY mice, HEPCIDIN
Abstract

Summary: We assessed the diagnostic potential of erythroferrone as a biomarker for iron homeostasis comparing iron deficiency cases with anaemia of inflammation and controls. The dysregulation of the hepcidin axis was observed by Latour et al. in a mouse model of malarial anaemia induced by prolonged Plasmodium infection leading to increased erythroferrone concentrations. In line with that, we found significantly higher erythroferrone levels in cases with malaria and anaemia in an African population, compared to asymptomatic controls. Therefore, our findings extend the previous ones of the mouse model, suggesting also a dysregulation of the hepcidin axis in humans, which should be further corroborated in prospective studies and may lay the basis for the development of improved treatment strategies according to ERFE concentrations in such patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023.

Author

Siller, Anita, Seekircher, Lisa, Astl, Manfred, Tschiderer, Lena, Wachter, Gregor A., Penz, Julia, Pfeifer, Bernhard, Huber, Andreas, Gaber, Manfred, Schennach, Harald, and Willeit, Peter

Subjects
IMMUNOGLOBULIN G, BLOOD donors, SEROPREVALENCE, BOOSTER vaccines, ANTIBODY titer
Abstract

Background: To provide updated estimates on SARS-CoV-2 antibody seroprevalence and average antibody titres for Central Europe. Methods: In repeat cross-sectional investigations (1 May 2022 to 9 March 2023) involving 28,768 blood donors in the Federal State of Tyrol, Austria (participation rate: 87.0%), we measured Spike receptor-binding domain (RBD) and Nucleocapsid IgG antibodies (37,065 and 12,645 samples), and estimated monthly seroprevalences and geometric mean titres. Results: Median age of participants was 45.4 years (range 18–70); 43.2% were female. Spike RBD IgG antibody seroprevalence was 96.3% (95% CI: 95.6–96.9%) in May 2022, 97.4% (96.7–98.0%) in December 2022, and 97.9% (96.4–98.8%) in March 2023. Among seropositive participants, geometric mean titres increased from 1400 BAU/mL (95% CI: 1333–1471) in May 2022 to 1821 BAU/mL (1717–1932) in December 2022, and dropped to 1559 BAU/mL (1405–1729) by March 2023. Furthermore, titres differed markedly by vaccination status and history of infection, with being the highest in participants with booster vaccination and prior infection. In autumn 2022, Nucleocapsid IgG antibody seroprevalence ranged from 36.5% (35.0–38.1) in September to 39.2% (37.2–41.2) in December 2022. Conclusion: Seroprevalence of SARS-CoV-2 antibodies in blood donors from Tyrol, Austria, was remarkably stable from May 2022 to March 2023. In contrast, average Spike RBD IgG antibody titres peaked in December 2022. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. Automatic Extension of a Semi-Detailed Synthetic Fuel Reaction Mechanism.

Author

Schmidt, Marleen, Eberl, Celina Anne Kathrin, Jacobs, Sascha, Methling, Torsten, Huber, Andreas, and Köhler, Markus

Subjects
SYNTHETIC fuels, CHEMICAL models, COMBUSTION kinetics, GLOBAL warming, LOW temperatures, IDENTIFICATION
Abstract

To identify promising sustainable fuels, e.g., to select novel synthetic fuels with the greatest impact on minimizing global warming, new methods for rapid and economical technical fuel assessment are urgently needed. Here, numerical models that are capable of predicting technical key data quickly and without experimental setup are necessary. One method is the use of chemical kinetic models, which are able to predict the technical key parameters related to combustion behavior. For a rapid technical fuel assessment, these chemical kinetic models need to be validated for new fuel components and for different temperature and pressure ranges. This work presents a new approach to extend the existing semi-detailed chemical kinetic models. For the application of the approach, the semi-detailed reaction mechanism DLR Concise was selected and extended for the low temperature combustion modeling of n-heptane and isooctane. The open-source software reaction mechanism generator (RMG) was used for this extension. Furthermore, an optimization of the merged chemical kinetic model with the linear transformation model (linTM) was conducted in order to improve the reproducibility of ignition delay times. The improvement of the predictive performance of ignition delay times at low temperatures for both species was successfully demonstrated. Therefore, this approach can be used to quickly add new species or reaction pathways to an existing semi-detailed reaction mechanism to enable a model-based technical fuel assessment for the early identification of promising fuels. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. Screening by Social Workers in Medical Patients with Risk of Post-Acute Care Needs: A Stepped Wedge Cluster Randomized Trial / Evaluation eines Screenings durch Sozialarbeiter bei medizinischen Patienten mit einem Risiko für post-akuten Nachsorgebedarf: eine stepped wedge clusterrandomisierte Studie

Author

Conca Antoinette, Ebrahim Doaa, Noack Sandra, Gabele Angela, Weber Helen, Prins Mehrnaz, Keller Anja, Hari Mariann, Engel Angela, Regez Katharina, Schild Ursula, Schuetz Philipp, Müller Beat, Haubitz Sebastian, Kutz Alexander, Huber Andreas, Faessler Lukas, and Schäfer-Keller Petra

Subjects
screening by social workers, post-acute care discharge score, discharge planning, social worker notification, self-referral, stepped wedge, screening durch sozialarbeiter, nachsorgebedarf, austrittsmanagement, sozialdienst-anmeldung, selbst-zuweisung, stepped-wedge-design, Public aspects of medicine, RA1-1270
Abstract

Elderly patients often need post-acute care after hospital discharge. Involvement of social workers can positively affect the discharge planning process.

Published
2018
Full Text
View/download PDF

20. Towards an Electronic Health Prevention Record Based on HL7 FHIR and the OMOP Common Data Model.

Author

FALGENHAUER, Markus, LAUSCHENSKY, Aaron, KREINER, Karl, BEYER, Stefan, REITER, Kristina, ZIEGL, Andreas, MODRE-OSPRIAN, Robert, PFEIFER, Bernhard, NEURURER, Sabrina, KRESTAN, Susanne, WAGNER, Hanna, HUBER, Andreas, PLAIKNER, Sandra, KUPPELWIESER, Sarah, WIDSCHWENDTER, Martin, and SCHREIER, Günter

Abstract

Background: Approximately 40% of all recorded deaths in Austria are due to behavioral risks. These risks could be avoided with appropriate measures. Objectives: Extension of the concept of EHR and EMR to an electronic prevention record, focusing on primary and secondary prevention. Methods: The concept of a structured prevention pathway, based on the principles of P4 Medicine, was developed for a multidisciplinary prevention network. An IT infrastructure based on HL7 FHIR and the OHDSI OMOP common data model was designed. Results: An IT solution supporting a structured and modular prevention pathway was conceptualized. It contained a personalized management of prevention, risk assessment, diagnostic and preventive measures supported by a modular, interoperable IT infrastructure including a health app, prevention record webservice, decision support modules and a smart prevention registry, separating primary and secondary use of data. Conclusion: A concept was created on how an electronic health prevention record based on HL7 FHIR and the OMOP common data model can be implemented. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Die Scholar:innen des IHS 1965-2015

Author

Huber, Andreas, Koenig, Thomas, and Castellucci, Clelia

Abstract

Input im Rahmen der Podiumsdiskussion: "Das IHS und die Professionalisierung der Sozialwissenschaften in Österreich" Das IHS wurde mit dem Auftrag gegründet, in Österreich moderne, empirische Sozialwissenschaften zu etablieren. Das bedeutet zweierlei: sowohl die österreichische Wissenschaftslandschaft mit etwas Neuem zu bereichern als auch im internationalen Setting einen weiteren Standort für sozialwissenschaftliche Innovation zu aufzubauen. Zum Anlass des runden Geburtstags des Instituts gilt es, eine kritische Bestandsaufnahme vorzunehmen: Wie gut ist das eine, wie weit das andere umgesetzt worden? Können messbare Ergebnisse vorgewiesen werden? Unter welchen Bedingungen finden Vertiefung und Innovation des sozialwissenschaftlichen Methoden- und Theoriewerkzeugkasten statt?

Published
2023

23. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Author

Vögeli, Alaadin, Ottiger, Manuel, Meier, Marc A., Steuer, Christian, Bernasconi, Luca, Huber, Andreas, and Christ-Crain, Mirjam

Subjects
Chronic obstructive lung disease -- Research, Arginine -- Dosage and administration -- Complications and side effects, Nitric oxide -- Health aspects, Health
Abstract

Introduction In chronic obstructive pulmonary disease (COPD), there is an activation of the l-arginine nitric oxide pathway. Pulmonary obstruction causes to elevated nitric oxide (NO) levels, which lead to higher production of the NO-inhibiting metabolites asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Methods We investigated the association of l-arginine, ADMA, and SDMA with clinical outcomes in a well-defined observational cohort of 150 patients with acute exacerbation of COPD. We measured l-arginine, ADMA, and SDMA by mass spectrometry in patients with pneumonic or non-pneumonic exacerbation of COPD included in a Swiss multicenter trial. We used Cox regression models to investigate the associations between blood marker levels and disease severity as well as all-cause mortality over a follow-up of 6.1 years. Results Six-year all-cause mortality was 54%. Admission levels of ADMA and SDMA ([mu]mol L.sup.-1) were increased in 6-year non-survivors compared to survivors' median (0.60 vs. 0.46, p = 0.004; and 1.05 vs. 0.85, p = 0.012). In a multivariate Cox regression analysis, ADMA was associated with long-term mortality resulting in an age- and comorbidity-adjusted hazard ratio (HR) of 4.55 (95% confidence interval 1.02-20.43, p = 0.048). SDMA was only associated in univariate models and no association of l-arginine with outcome was found. Conclusion ADMA was found to be an independent risk factor for long-term all-cause mortality in patients with acute exacerbation of COPD. Whether therapeutic modification of the l-arginine-nitric oxide pathway has the potential to improve outcome should be evaluated in future interventional trials., Author(s): Alaadin Vögeli [sup.1] , Manuel Ottiger [sup.1] , Marc A. Meier [sup.1] , Christian Steuer [sup.2] , Luca Bernasconi [sup.2] , Andreas Huber [sup.2] , Mirjam Christ-Crain [sup.3] , [...]

Published
2017
Full Text
View/download PDF

24. Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study

Author

Blum, Claudine Angela, Winzeler, Bettina, Nigro, Nicole, Schuetz, Philipp, Biethahn, Silke, Kahles, Timo, Mueller, Cornelia, Timper, Katharina, Haaf, Katharina, Tepperberg, Janina, Amort, Margareth, Huber, Andreas, Bingisser, Roland, Sándor, Peter Stephan, Nedeltchev, Krassen, Müller, Beat, Katan, Mira, and Christ-Crain, Mirjam

Published
2017
Full Text
View/download PDF

32. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Author

Schröder, Fritz H, Hugosson, Jonas, Roobol, Monique J, Tammela, Teuvo L J, Zappa, Marco, Nelen, Vera, Kwiatkowski, Maciej, Lujan, Marcos, Määttänen, Liisa, Lilja, Hans, Denis, Louis J, Recker, Franz, Paez, Alvaro, Bangma, Chris H, Carlsson, Sigrid, Puliti, Donella, Villers, Arnauld, Rebillard, Xavier, Hakama, Matti, Stenman, Ulf-Hakan, Kujala, Paula, Taari, Kimmo, Aus, Gunnar, Huber, Andreas, van der Kwast, Theo H, van Schaik, Ron H N, de Koning, Harry J, Moss, Sue M, and Auvinen, Anssi

Published
2014
Full Text
View/download PDF

36. Prediction of post-acute care demand in medical and neurological inpatients: diagnostic assessment of the post-acute discharge score – a prospective cohort study

Author

Conca, Antoinette, Gabele, Angela, Reutlinger, Barbara, Schuetz, Philipp, Kutz, Alexander, Haubitz, Sebastian, Faessler, Lukas, Batschwaroff, Marcus, Schild, Ursula, Caldara, Zeljka, Regez, Katharina, Schirlo, Susanne, Vossler, Gabi, Kahles, Timo, Nedeltchev, Krassen, Keller, Anja, Huber, Andreas, De Geest, Sabina, Buergi, Ulrich, Tobias, Petra, Louis Simonet, Martine, Mueller, Beat, and Schäfer-Keller, Petra

Published
2018
Full Text
View/download PDF

50. Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantification of procalcitonin in emergency department patients and established reference methods - a prospective multinational trial

Author

Kutz, Alexander, Hausfater, Pierre, Oppert, Michael, Alan, Murat, Grolimund, Eva, Gast, Claire, Alonso, Christine, Wissmann, Christoph, Kuehn, Christian, Bernard, Maguy, Huber, Andreas, Mueller, Beat, and Schuetz, Philipp

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results